Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2024 Mar 14;14:6168. doi: 10.1038/s41598-024-56371-0

Knowledge, attitudes, and associated factors towards HIV pre-exposure prophylaxis among health care providers

Getachew Mekonnen 1,, Tiliksew Liknaw 2, Alemayehu Anley 3, Abebe Dilie Afenigus 2
PMCID: PMC10940609  PMID: 38485990

Abstract

The knowledge and attitudes of health care providers were limited as reviewed in many studies. Attitudes and knowledge about pre-exposure prophylaxis among healthcare providers have not been investigated in Ethiopia even though pre-exposure prophylaxis is a novel healthcare topic. The aim was to assess knowledge, attitudes, and associated factors towards pre-exposure prophylaxis among healthcare providers in Gojjam health facilities, North West Ethiopia, 2022. An institutional-based cross-sectional study was conducted from June 1–30 among 410 healthcare providers in public health facilities in the East Gojjam zone. A simple random sampling technique was used to recruit the required study participants. The statistical program EPI Data version 4.6 was used to enter the data, and statistical packages for Social science version 25 was used for analysis. Variables with a p-value less than 0.25 in the bivariable analysis were included in the multivariable logistic regression analysis. Statistical significance was determined with a p-value less than 0.05. The good knowledge and the favorable attitude of healthcare providers toward HIV pre-exposure prophylaxis were 55.7% (50.6–60.2%) and 60.2% (55.0–65.0%) respectively. male participant (AOR 1.67; 95% CI (1.01–2.55), service year ≥ 10 years (AOR 2.52; 95% CI (1.23–5.17), favorable attitudes (AOR 1.92; 95%CI (1.25–2.95), and providers good sexual behavior (AOR 1.85; 95%CI (1.21–2.82) were significantly associated with the good knowledge, and training (AOR 2.15; 95% CI (1.23–3.76), reading the guideline (AOR 1.66; 95% CI (1.02–2.70), and good knowledge (AOR 1.78; 95% CI (1.16–2.75) was significantly associated with the favorable attitudes. In general, the finding of this study shows that the knowledge and attitudes of healthcare providers were low. Since this is a new initiative their knowledge is lower than their attitudes. Male, service year 10 years, and good provider sexual behavior were factors significantly associated with good knowledge. Training, reading the guidelines, and good knowledge were factors significantly associated with a favorable attitudes. As a result, healthcare facilities intervention programs and strategies better target these factors to improve the knowledge and attitudes of healthcare providers. Preparing training programs to enhance knowledge and attitudes towards PrEP is recommended.

Keywords: Knowledge, Attitudes, Healthcare provider, And Pre-exposure prophylaxis

Subject terms: Diseases, Health care

Introduction

Background

HIV/AIDS is among chronic infectious diseases and the primary global burden of diseases1. Currently, there is a new strategy to prevent newly acquired infection of the human immunodeficiency virus (HIV) for people exposed to HIV/AIDS by once-daily taking medications called pre-exposure prophylaxis. Pre-exposure prophylaxis (PrEP) is an effective prevention against HIV, approved by the World Health Organization (WHO) in 2015, and by the United States Food and Drug Administration (UFDA) in 20122,3. Ethiopia approved tenofovir (TDF)/ lamivudine (3TC) HIV prevention and considered HIV PrEP as one of the six pillars for HIV prevention for HIV-negative people in 20194.

PrEP has been widely regarded as a biomedical prevention strategy for highly vulnerable population groups to contracting HIV5. Several clinical trials have demonstrated unequivocally the effectiveness of a combination of TDF/3TC fixed-dose combination used as per the WHO recommendation in reducing the risk of HIV transmission6. The WHO has recently recommended its adoption as one of the strategies to combat new HIV infections among individuals at substantial risk of HIV (commercial sex workers and discordant)7. If taken daily by an HIV- negative individual, PrEP provides over 90% reduction in HIV acquisition8.

Several African countries have already approved guidelines for tenofovir plus emtricitabine, although Ethiopia approved tenofovir plus lamivudine-based PrEP for HIV prevention to individuals at substantial risk of HIV as part of combination HIV prevention despite key questions remain about how to identify and deliver PrEP to those in greatest need4,911. Throughout the continent, individuals in serodiscordant relationships and Sex workers are likely to benefit from the availability of PrEP. It has been estimated that at least three million individuals in Africa are likely to be eligible for PrEP according to WHO's criteria12.

Health Care professionals must be aware of and willing to administer PrEP to apply PrEP guidelines and effectively deliver PrEP to at-risk groups. Provider acceptability studies have been primarily undertaken in PrEP research studies in North America5,8,13,14. Understanding provider concerns and challenges to PrEP knowledge and attitudes in distinct geographical and cultural settings has the potential to increase PrEP coverage among critical populations, helping to achieve the overarching objective of regional and global HIV incidence reduction15.

Despite these developments, the use of PrEP among those at the highest risk of HIV acquisition has been slow. Until March 2022 only 2870 people in Ethiopia have received a prescription for PrEP out of 14,046 eligible PrEP users who attend health facilities. The estimated cumulative number of people to initiated PrEP was 16,000 to 17,000, this indicates that there is a huge gap between the eligible people and the access to PrEP16.

Different strategies have been implemented to cope with this problem in Ethiopia including USAIDS targets of 95–95–95, the HIV/AIDS strategic plan to end HIV transmission by 2030 and reduce HIV as a public health threat, an implementation manual for pre-exposure prophylaxis of HIV infection, also national comprehensive HIV care guideline recommends PrEP for clients at substantial risk of HIV infection4,17.

The Federal Ministry of Health 2019 released HIV-PrEP guidelines including oral tenofovir/ lamivudine fixed-dose as a PrEP for a person who has a risk but is not yet infected with HIV according to the clinical benefit of HIV-PrEP18.

Health providers that work in African countries have low knowledge of PrEP and the knowledge ranges from 3.5% in Tanzania to 67% in Kenya5,1925. The magnitude of the attitudes of healthcare providers toward PrEP is not similar around the world. The pooled prevalence of providers' attitudes about PrEP is 66% in the USA, 70% in England, and 79 in Italy out of European countries6,23,26. Unlike European and American countries the attitudes of health providers in Africa is below 60% in Tanzania, Uganda, Botswana, and South Africa10,24.

HIV PrEP services should be given by a provider that has good knowledge and a favorable attitude. Despite this, if it is given by a provider with poor knowledge and unfavorable attitudes could have many consequences such as increased new HIV acquisition, poor patient adherence to ART medication, development of HIV drug resistance, decreased willingness to new PrEP users, decreased number of follow up patients, and an increase in the incidence of other sexually transmitted diseases14,27. It also decreases the satisfaction of substantial-risk individuals with PrEP service and decreases provider-to-user relationships28.

Providers who have poor knowledge and unfavorable attitudes still represent a significant barrier for substantial risk individuals seeking PrEP2931. The knowledge and attitudes towards HIV pre-exposure prophylaxis among health care providers working in health care facilities in Ethiopia have not yet been studied. Therefore, this study aims to assess the knowledge, attitudes and associated factors towards HIV pre-exposure prophylaxis among healthcare providers working in East Gojjam zone health facilities.

Methodology

Study area, period, and design

A multi-institutional based cross-sectional study was conducted from June 1 to 30 in the East Gojjam zone, North West Ethiopia. The total number of healthcare work providers in the study area was 51832. Based on the Amhara Regional Health Bureau report there are eleven hospitals and 102 health centers under the zone33. Eleven hospitals and fifteen health centers are providing PrEP services for those substantial risk individuals34.

Population

The source populations were healthcare providers (physicians, health officers, nurses, and midwives) who were working in ART, VCT, and PMTCT in the East Gojjam zone public health facilities and The study populations of this study were healthcare providers (physicians, health officers, nurses, and midwives) who were working in ART, VCT, and PMTCT during the study period.

Inclusion and exclusion criteria

All Healthcare providers (physicians, health officers, nurses, and midwives) who were working in ART, VCT, and PMTCT during the study period were included in the study. HCPs who were sick and on annual leave at the time of data collection were excluded from the study.

Sample size determination

The sample size was determined by using a single population proportion formula with the assumption of 59% and 67% of the overall prevalence of knowledge and attitudes of healthcare workers towards HIV PrEP from the previous studies done in Kenya respectively25. 95% confidence level and 5% margin of error. Based on this study the actual sample size for the study was computed by using a single population proportion formula.

n=Za/22P1-p/d2

where n = sample size of the population, Z = critical value of 95% CI = 1.96, P = Proportion of knowledge or attitudes of PrEP taken as above (0.5) D = precision (marginal error) = 0.05.

The sample size of attitudes

N=1.962×0.59×0.41/0.052=372

The sample size of knowledge

N=1.962×0.67×0.33/0.052=340

Then, by adding 10% for possible non-response rate the total sample size by knowledge and attitudes was 410 and 379 respectively. The sample size for the third and fourth objectives was determined using Epi-info 7 software with the assumption of 95% CI, 5% margin of error, 80% power, and exposure to an unexposed ratio of 1:1 (Table 1).

Table 1.

Sample size calculation by third and fourth objectives.

Factors P (%) Power CI OR Sample size Adding 10% non-responses Total sample size Reference
Age (years)  ≤ 34 year 81.2 80% 95% 3.7 104 11 115 35
 > 34 year 53.8
Sex Male 67 80% 95% 2.11 256 26 282 36
Female 49
Profession Physician 70 80% 95% 2.24 228 23 251 20
Nurse 51
Service year  < 10 yrs 55 80% 95% 2.32 218 22 240 23
 ≥ 10 yrs 74

CI confidence interval, OR crude odd ratio, P proportion in percent.

Then, from the above list of sample sizes, the large sample is 410, and it was taken as the final sample of the population.

Sampling techniques

A simple random sampling technique was used to select the study participants after allocating participants from public health facilities by proportional allocation to the population. The list of health providers taken from the matron and chief medical officer was used as a sampling frame and study participants were selected by lottery method until 410 health providers from a total of 518 HCPs in the working area (Fig. 1).

Figure 1.

Figure 1

Schematic presentation of sampling procedure on knowledge, attitude, and associated factors of HIV pre-exposure prophylaxis among health providers who were working in ART, VCT, AND PMTCT in East Gojjam zone public health facility, NW Ethiopia, 2022.

Study variables

Dependent variables

Knowledge and attitudes of HCPs towards HIV Pre-Exposure Prophylaxis.

Independent variables

Socio-demographic factors: sex, age, marital status, profession, and educational level.

Sexual risky behavioral factors: Ask about sexual activity, discuss sexual behavior, offer HIV test for adults who needs treatment, refer high-risk patients, and offer PrEP for high-risk individuals.

Work-related factors: Place of work, service year, working area/ward, availability of resources, history of working in PEP, Training, and the number of patients served per day.

Operational definitions, data collection tools, procedures, and techniques

Pre-exposure prophylaxis (PrEP)

PrEP is an evidence-based HIV risk-reduction intervention with two ART drug combinations (TDF/3TC) that is offered to commercial sex workers and serodiscordant couples at risk of acquiring HIV37.

Attitudes

The attitudes of healthcare providers were measured with standardized tool and who scored greater than or equal to the mean from the total attitudes-related questions were considered to have favorable attitudes towards PrEP. There are 13 attitudes-related questions that had a Likert scale scored 1, 2,3,4, and 5 for strongly disagree, disagree, neutral, agree, and strongly agree respectively those who scored agree and strongly agree are considered to have favorable attitudes38.

Knowledge

Healthcare providers who answer ≥ 70% of total knowledge-related questions regarding PrEP have good knowledge whereas healthcare providers who scored below 70% of knowledge-related questions were considered as having poor knowledge36.

Behaviors/practices regarding providers’ HIV testing and pre-exposure prophylaxis

Someone is considered as having good Behaviors/practices regarding providers’ HIV testing and pre-exposure prophylaxis, at least if he/she answers often and always on a 5-point Likert scale from six questionnaires, and those who answered never, rarely, and sometimes were considered as having poor Behaviors/practices39.

Data were collected using a structured and pretested self-administered questionnaire. The questionnaire and the consent form were prepared in English. The data were collected by 11 trained BSc degree nurses and were supervised by 3 MSc nurses and 2 public health professionals having previous experience in data collection. The data were collected using a simple random sampling technique by using a lottery method and approached privately on arrival without disturbing the routine working activity in the health facility. The objective of the study was explained to them using study-specific information and enough time was given to make an independent decision to participate in the study.

Data quality assurance and control

Data quality was controlled by giving training and appropriate supervision for data collectors. One day of training was provided to the data collectors and the supervisor on the aim of the study, how to use the questionnaire, how to approach study participants, and how to collect data and supervise.

The questionnaires were evaluated by three HIV/AIDS experts (a physician and an MSc nurse) before the data collection. The questionnaire was arranged based on the content validity index (CVI) format and sent to those experts via email to give their evaluation. Based on their responses I-CVI scores were calculated by dividing the expert agreement by the number of experts, and finally, the average of I-CVI scores across all items was computed. Based on this procedure the S-CVI was 0.86 for knowledge and 0.88 for attitudes-related questions. Which indicates the tool is acceptable.

A pretest was conducted on 5% (n = 21) of the total sample size at Finote Selam General Hospital. The reliability of the tool was checked before data collection with alpha coefficients for the knowledge, attitudes, and providers' sexual behavior scales of 0.739, 0.726, and 0.778, respectively. Continuous follow-up and supervision were also made by the principal investigator throughout the data collection period. A review was made to check the completeness of the questionnaire and corrections was made. Each questionnaire and data sheet was checked before the data entry. The data was entered daily for nearby sites and every week for those far sites and there was no identified major missing data.

Data processing and analysis

The data were checked for discrepancies and completeness. The data were entered using Epi-data version 4.6. Then the data were cleaned, coded, and analyzed using SPSS version 25. The Multicollinearity between each independent variable was checked and there was no correlation between the independent variables with the Variance inflation factor (VIF) with a maximum value of 2.3 and the Tolerance test with a minimum value of 43.6%.

Hosmer and Lemeshow's goodness of fit test was used to test the model adequacy using a p-value (p = 0.615) for knowledge and (P = 0.269) for attitudes model fit. Variables having a p-value < 0.25 in a bi-variable analysis were entered into a multivariable binary logistic regression model to adjust for possible confounders. P-value < 0.05 and odds ratio (OR) with a 95% confidence interval were considered as a measure of statistically significant variables in this study. The result was described and expressed by using tables, graphs, and narrative descriptions.

Ethical approval and consent to participate

Ethical clearance was obtained from the Debre Markos University, College of Health Sciences Ethical and Research review committee with an ethical clearance reference number of HSC/R/C/Ser/PG/Co/214/11/14. A formal letter of cooperation was written to eleven hospitals and other fifteen health centers. All methods were performed according to relevant guidelines and regulations. Informed consent was obtained from each study participant. Data was kept anonymously in the distributed questionnaire to keep confidentiality.

Results

Socio-demographic characteristics of healthcare providers

A total of 397 healthcare providers were included in the study, giving a response rate of 96.8%. Of the total participants, 314 (79.1%) healthcare providers ranged from 25 to 34 years old with a mean age of 29.48 with SD ± 4.07 years. The majority of the participants 255 (64.2%), were married and 218 (54.9%) of the participants were male by sex. Regarding the profession of participants around 213 (53.7%) were nurses, and 290 (73.0%) participants were first-degree holders (Table 2).

Table 2.

Socio-demographic characteristics of health care providers who are working in ART, VCT, and PMTCT in East Gojjam zone public health facility, Northwest Ethiopia, 2022.

Variable Category Frequency Percentage (%)
Age (years) 20–24 years 16 4.0
25–34 years 314 79.1
 > 34 years 67 16.9
Sex Female 179 45.1
Male 218 54.9
Marital status Single 128 32.2
Married 255 64.2
Divorced 14 3.5
Religion Orthodox 334 84.1
Muslim 60 15.1
Catholic 1 .30
Protestant 2 .50
Profession Midwives 94 23.7
Nurse 213 53.7
Public health Officer 57 14.4
Doctors 31 7.8
Specialist 2 .50
Educational level Diploma 85 21.4
First degree 290 73.0
Second degree 22 5.5

Providers' work-related characteristics

Among 397 study participants, 205 (51.7%) participants were from the hospital, and 180 (45.3%) study participants were working in ART. 200 (50.4%) participants had work experience of 5 -10 years, but only 117 (29.5%) participants had received the training on PrEP. Two hundred sixty-eight (67.5%) of study participants read the current Ethiopian PrEP implementation guideline. The majority (97.5%) of participants heard about PrEP and the main source of information was from the health facility (Table 3).

Table 3.

Work-related characteristics of health care providers who are working in ART, VCT, and PMTCT at East Gojjam zone public health facility, Northwest Ethiopia, 2022.

Variable Category Frequency Percent (%)
Workplace Health center 192 48.3
Hospital 205 51.7
Working area/ward/ PMTCT 101 25.4
VCT 116 29.2
ART 180 45.3
been working in PEP No 196 49.4
Yes 201 50.6
Service year  < 5 year 142 35.8
5–10 year 200 50.4
 > 10 year 55 13.9
Training on PrEP No 280 70.5
Yes 117 29.5
Have you heard about HIV PrEP No 10 2.5
Yes 387 97.5
Available resource PrEP guidelines 110 27.7
Literature 21 5.3
PrEP medications 149 37.5
Books 11 2.8
All 106 26.7
Read PrEP guidelines No 129 32.5
Yes 268 67.5
Number of patients served per day 0–5 patients 18 4.5
6–20 patients 257 64.7
 > 20 patients 122 30.7

The majority of the participants get information about PrEP from a health facility (Fig. 2).

Figure 2.

Figure 2

Source of information about HIV pre-exposure prophylaxis who are working in ART, VCT, AND PMTCT in East Gojjam zone public health facility HCPs, Northwest Ethiopia, 2022.

Sexual behavior-related characteristics of healthcare workers

Seventy-two (18%) and 204 (51.4%) providers reported always or very often asking adult patients about their sexual activity. Two-thirds of providers reported always or very often offering HIV tests to sexually active adults who had not been previously tested for HIV, while the remaining one-third reported sometimes, rarely, or never doing so. About 276 (69.5%) of providers were reported always or very often offering HIV tests to adults seeking treatment for another sexually transmitted infection (STI). Twelve respondents (3%) reported never offering to test such patients. Just over 267 (68%) of providers always or very often refer high-risk patients to an HIV (or infectious disease) specialist after a positive test result. Generally, study participants have good sexual behavior in linking their patients to HIV testing but they have a limitation on prescribed PrEP (Fig. 3).

Figure 3.

Figure 3

Behaviors/practices regarding providers’ HIV testing and pre-exposure prophylaxis among HCPs who are working in ART, VCT, and PMTCT in East Gojjam zone public health facility, Northwest Ethiopia, 2022.

Knowledge of healthcare providers

Out of the 397 study participants, 221 (55.7%) with 95% CI (50.6–60.2) of the respondents had good knowledge, and 176 (44.3%) with 95% CI (39.8–49.4) had poor knowledge. Just below 1/3 of the providers 117 (29.47%) reported having trained in Ethiopian PrEP clinical practice guidelines, and around 221 (55.7%) of providers correctly answered 8 and above out of 11 knowledge-related questions. Of a total of 241 participants who read the guideline only 58.5% had good knowledge; also HCPs who serve greater than 20 patients per day were knowledgeable (59.4%) (Table 4).

Table 4.

Knowledge of health care providers (working in ART, VCT, AND PMTCT) towards PrEP among healthcare providers of East Gojjam zone public health facilities, Northwest Ethiopia, 2022.

Variables Categories Count Percent (%)
Aware that HIV testing is important before starting PrEP Yes 328 82.6
No 69 17.4
Which laboratory test is necessary for initial follow-up tests HIV test 176 44.3
serum creatinine 101 25.4
widal-wiflex test 38 9.6
screen for STI 72 18.1
pregnancy test 10 2.5
For which of the following patients should PrEP be recommended An HIV + client who lives lonely 56 14.1
A serodiscordant negative couple 190 47.9
An HIV −ve couple who has an HIV −ve partner 42 10.6
Commercial sex workers 109 27.5
Number of PrEP drugs used for prevention One 56 14.1
Two 241 60.7
Three 100 25.2
Which medication is approved for use as PrEP? Abacavir/lamivudine (ABC/3TC) 53 13.4
Dolutegravir/tenofovir (DTG/TDF) 104 26.2
Tenofovir/lamivudine/doltegravir (TDF/3TC/DTG) 97 24.4
Tenofovir/lamivudine (TDF/3TC 143 36.0
When taken daily, how efficacious is PrEP at reducing HIV acquisition risk? 50–60% 26 6.5
61–70% 66 16.6
71–80% 38 9.6
81–90% 75 18.9
Greater than 90% 192 48.4
Which of the following is an adverse effect of PrEP that requires routine laboratory monitoring? Hepatotoxicity 142 35.8
Reduced renal function 157 39.5
Bone mineral density loss 49 12.3
Dyslipidemia 27 6.8
Anemia 22 5.5
How often do patients taking PrEP require HIV screening? Only after potential HIV exposures 30 7.6
Monthly 57 14.4
Every 3 months 264 66.5
Every 6 months 36 9.1
Every 12 months 10 2.5
Which patients are excluded from PrEP service according to Ethiopian PrEP guideline Patients who have HIV infection 126 31.7
Patients with Cr level ≥ 60 ml/min 164 41.3
Presence of HBV 54 13.6
Patients on MDR TB treatment 53 13.4
When to stop PrEP service after initiation After a patient HIV positive test 125 31.5
When a patient develops a renal disease 98 24.7
When a patient is adherent to treatment 129 32.5
When a patient does not need PrEP 45 11.3
Recommended routine monitoring tests for all patients taking PrEP Kidney function test 57 14.4
Liver function test 165 41.6
Hepatitis B serology 50 12.6
Stool analysis 55 13.9
HIV screen 70 17.6

Of the respondents, 82.6 percent were aware that HIV testing is important before starting PrEP and 74.75% of participants answered that commercial sex workers and serodiscordant negative couples are eligible for PrEP service. Concerning the number of drugs used for PrEP 61% of the respondents are familiar with two drugs used, but most of the health care providers lack the knowledge to differentiate which drugs and the effectiveness of the regime, 36.2% answered Tenofovir/lamivudine (TDF/3TC and (48.4%)) answered that PrEP is effectively greater than 90%. Most study participants lack knowledge related to the adverse effect, and the exclusion criteria of PrEP drugs were mostly answered below 50.0%%, which are 39.55%, 40.3%, and 48.4% respectively.

Factors affecting the knowledge of healthcare providers

Logistic regression analyses were performed to identify factors significantly associated with good HIV-PrEP knowledge. Those variables' p values less than 0.25 (age, sex, profession, educational level, working place, working area, worked in PEP, service year, training, reading the guideline, number of patients served, attitudes, and risky sexual behavior and HIV testing practice) were entered into multivariable logistic regression. Regarding a positive knowledge of HIV-PrEP, bivariable logistic regression showed several factors were significantly associated with this parameter. Being a male, serving more than 10 years, providers having favorable attitudes and good sexual behavior activity to HIV testing were the independent factors associated with a positive knowledge of HIV-PrEP in multi-variable logistic regression analysis.

The odds of having good knowledge were 2.5 times higher among healthcare providers who have more than 10 years of experience than HCPs having less than 5 years of experience [AOR] 2.52, 95% confidence interval [CI] (1.23–5.17) P-value: 0.012. The odds of healthcare providers’ knowledge among males were 1.7 times more likely to be knowledgeable than female healthcare providers (AOR 1.67, 95% CI ( 1.01–2.55) P-value: 0.017.

The knowledge of healthcare providers was also highly associated with the attitudes of study participants, the odds of having good PrEP knowledge were nearly 2 times higher among those who had favorable attitudes as compared to healthcare providers who had unfavorable attitudes about PrEP (AOR 1.92, 95% CI (1.25–2.95) P-value:0.003.

The other significantly associated independent variable with knowledge of PrEP during multiple logistic regressions was the sexual behavior of health care providers, the odds of having good knowledge of PrEP were 1.8 times higher among providers who had good sexual behavior and HIV testing practice as compared to HCPs who had poor sexual behavior and HIV testing practice (AOR 1.85, 95% CI (1.21–2.82) P-value: 0.004 (Table 5).

Table 5.

Factors associated with knowledge of health care providers who are working in ART, VCT, AND PMTCT in East Gojjam zone public health facility, Northwest Ethiopia, 2022.

Knowledge OR with 95% CI P
Poor knowledge Good knowledge COR AOR
Age 20–24 years 8 8 1 1
25–34 years 148 166 1.12 (0.41, 3.06) 0.62 (0.20, 1.93) 0.410
 > 34 years 20 47 2.35 (0.77, 7.14) 0.48 (0.12, 1.95) 0.302
Sex Female 91 88 1 1
Male 85 133 1.62 (1.09, 2.42) 1.67 (1.10, 2.60) 0.017
Profession Midwives 49 45 1 1
Nurse 91 122 1.46 (0.90, 2.38) 1.04 (.61,1.77) 0.897
PHO 25 32 1.39 (0.719, 2.70) 0.54 (0.25, 1.17) 0.120
Doctors 11 22 2.18 (0.95, 4.99) 1.87 (0.75, 4.70) 0.182
Educational level Diploma 48 37 1 1
1st degree 123 167 1.76 (1.08, 2.87) 1.41 (.81,2.47) .224
2nd degree 7 15 2.78 (1.49, 4.05) 2.18 (0.62, 5.71) 0.228
Service year  < 5 year 73 69 1 1
5–10 year 89 111 1.32 (0.86, 2.03) 1.26 (0.80, 1.98) 0.313
 > 10 year 14 41 3.10 (1.55, 6.18) 2.52 (1.23,5.17) 0.012
Working area PMTCT 53 48 1 1
VCT 57 59 1.14 (0.67, 1.95) 0.98 (0.20, 4.81) 0.982
ART 66 114 1.91 (1.16,3.13) 1.18 (.24,5.79) 0.840
Working in PEP No 102 94 1 1
Yes 74 127 1.86 (1.25, 2.78) 1.43 (.83,2.46) 0.196
Read PrEP guidelines No 67 62 1 1
Yes 109 159 1.58 (1.03, 2.41) 0.97 (0.58, 1.62) 0.900
Training No 139 141 1 1
Yes 37 80 2.13 (1.35, 3.36) 1.52 (0.89, 2.58) 0.123
Number of patients served / day 0- 5 pts 11 7 1 1
6–20 pts 122 135 1.74 (0.65, 4.63) 1.76 (0.63, 4.90) 0.278
 > 20 pts 43 79 2.89 (1.04, 7.99) 2.86 (0.99, 8.26) 0.052
Attitude Unfavorable attitude 88 73 1 1
favorable attitude 88 148 2.02 (1.35, 3.05) 1.92 (1.25, 2.95) 0.003
Providers sexual behavior Poor sexual bhr 102 79 1 1
Good sexual bhr 74 148 2.48 (1.65, 3.72) 1.85 (1.21, 2.82) 0.004

CI confidence interval, COR crude odds ratio, AOR adjusted odds ratio.

Attitudes of healthcare providers toward PrEP

The mean score of the total attitudes questions was 43 with SD ± 6.58. Out of the total of 397 study participants, 239 (60.2%) with 95% CI (55.0–65.0) of the respondents had a favorable attitudes, and 158 (39.8%) with a 95% CI (34.9–44.8) had an unfavorable attitudes.

Of the respondents, 322 (81.1%) agree and strongly agree that 3TC/TDF is a safe drug to use as PrEP. One hundred forty-nine (48.6%) of participants agreed that PrEP is an effective prevention tool in the real world. In addition, 249 (62.7%) of the participants also believe that PrEP is more effective than PEP. Fifty-five percent of participants also believe that PrEP will put their patients under discrimination, 250 (63%) also agreed and strongly agreed that PrEP leads to an increase in sexually transmitted diseases (Table 6).

Table 6.

Attitudes of health care providers who are working in ART, VCT, AND PMTCT in East Gojjam zone public health facility, Northwest Ethiopia, 2022.

Attitude questions Strongly disagree Disagree Neutral Agree strongly agree
Believe PrEP has a greater impact than testing and care on the HIV epidemic 24 97 30 194 52
6.00% 24.40% 7.60% 48.90% 13.10%
Believe PrEP will not affect the funding of other prevention methods 26 120 24 198 29
6.50% 30.20% 6.00% 49.90% 7.30%
Agree with PrEP is an effective prevention tool in the real world 22 104 44 193 34
5.50% 26.20% 11.10% 48.60% 8.60%
Believe that PrEP has little impact on ARV resistance 15 140 23 195 24
3.80% 35.30% 5.80% 49.10% 6.00%
Believe that Patients will adhere to daily PrEP 12 127 28 197 33
3.00% 32.00% 7.10% 49.60% 8.30%
Believe that PrEP will have a greater impact than behavioral interventions on preventing HIV infection 30 125 17 194 31
7.60% 31.50% 4.30% 48.90% 7.80%
Believe that PrEP will lead to an increase in STIs 33 96 18 214 36
8.30% 24.20% 4.50% 53.90% 9.10%
Do you agree with PrEP should be widely available based on current evidence 21 78 34 234 30
5.30% 19.60% 8.60% 58.90% 7.60%
Believe that Taking PrEP will put my patients at risk of sexual or physical coercion 25 86 24 239 23
6.30% 21.70% 6.00% 60.20% 5.80%
Believe that PrEP is more effective than PEP for frequent PEP users 11 75 26 249 36
2.80% 18.90% 6.50% 62.70% 9.10%
Believe that Patients will not perceive to be HIV positive if taking PrEP 20 106 30 215 26
5.00% 26.70% 7.60% 54.20% 6.50%
I am worried that my patients will be stigmatized for taking PrEP 40 153 22 165 17
10.10% 38.50% 5.50% 41.60% 4.30%
Believe that 3TC/TDF is a safe drug to use as PrEP 13 45 17 284 38
3.30% 11.30% 4.30% 71.50% 9.60%

Factors affecting attitudes of health care providers toward PrEP

Logistic regression analyses were performed to identify factors significantly associated with favorable attitudes toward HIV-PrEP. There were 12 factors (age, marital status, profession, educational level, working area, worked in PEP, service year, training, reading the guideline, heard about PrEP, knowledge, and providers' risky sexual behavior) found to be significantly associated with a favorable attitude of health care providers towards HIV-PrEP in bivariable analysis, but only the following 4 factors (training, reading the guideline, good knowledge, and profession) were identified as independent factors of attitudes of health care providers towards HIV-PrEP in multivariable analysis.

The odds of having favorable attitudes among nurses were 2.7 times more favorable than medical doctors (AOR 2.70, 95% CI (1.19–6.14) P-value: 0.018. The odds of having favorable attitudes among those who take basic PrEP training had 2 times more likely favorable attitudes than healthcare providers who didn’t train in the basic PrEP guidelines. (AOR 2.15, 95% CI (1.23–3.76) P-value: 0.008.

The favorable attitudes of healthcare providers were also highly associated with reading the PrEP guideline, the odds of having favorable PrEP attitudes among those who read the guideline were nearly two times higher than healthcare providers who didn’t read about PrEP guideline (AOR 1.66, 95% CI (1.02–2.70) P-value: 0.041.

The favorable attitudes of healthcare providers were also highly associated with the good knowledge of study participants. The odds of having a favorable attitude were two times higher among those who had good knowledge as compared to healthcare providers who had unfavorable attitudes about PrEP. (AOR 1.78, 95% CI (1.16–2.75) P-value: 0.009 (Table 7).

Table 7.

Factors associated with attitudes of health care providers who are working in ART, VCT, AND PMTCT in East Gojjam zone public health facility, Northwest Ethiopia, 2022.

Variables and category Attitudes of HCPs Odds ratio and confidence interval P
Unfavorable attitude Favorable attitude COR AOR
Age 20–24 years 9 7 1
25–34 years 133 181 1.75 (0.64, 4.81) 1.59 (0.54, 4.68) 0.405
 > 34 years 19 48 3.25 (1.05, 9.97) 2.20 (0.63, 7.71) 0.217
Profession Midwives 47 47 0.94 (0.43, 2.08) 1.88 (0.75, 4.71) 0.177
Nurse 74 139 1.77 (0.85, 3.70) 2.70 (1.19, 6.14) 0.018
PHO 24 33 1.29 (0.55, 3.06) 1.28 (.51, 3.22) 0.599
Doctors 16 17 1
Educational level Diploma 37 48 1
1st degree 120 170 1.09 (0.67, 1.87) 1.03 (0.61, 1.76) 0.909
2nddegree 8 14 1.35 (1.08, 6.21) 1.28 (0.96, 3.76) 0.056
Working area PMTCT 53 48 1
VCT 51 65 1.41 (0.82, 2.41) 0.85 (0.19, 3.90) 0.835
ART 57 123 2.38 (1.44, 3.93) 1.01 (0.22, 4.69) 0.992
worked on PEP No 90 106 1
Yes 71 130 1.56 (1.04, 2.33) 0.88 (0.54, 1.41) 0.583
Service year  < 5 year 61 81 1
5–10 year 82 118 1.08 (0.70, 1.67) 0.76 (0.46, 1.27) 0.298
 > 10 year 18 37 1.55 (0.80, 2.98) 0.91 (0.36, 2.33) 0.851
Training No 131 149 1.00
Yes 30 87 2.55 (1.58, 4.11) 2.15 (1.23, 3.76) 0.008
Read the guideline No 74 70 1
Yes 87 166 2.01 (1.33, 3.06) 1.66 (1.02, 2.71) 0.041
Knowledge Poor knowledge 88 88 1
Good knowledge 73 148 2.03 (1.35, 3.05) 1.78 (1.16, 2.75) 0.009
providers sexual behavior Good sexual behavior 97 84 1
Good sexual behavior 64 152 2.74 (1.82, 4.15) 1.46 (0.93, 2.31) 0.103

Discussion

In this study, the majority of participants 369 (92.9%) with 95% CI (90–95.3) heard about PrEP for HIV which is higher as compared to previous studies like research conducted in Deland Florida (75%), and in Rwanda, 86.4% of respondents heard about HIV PrEP39,40. This might be due to the difference in the period of adoption of the program and training opportunities.

In this study, the good knowledge of health care providers about HIV PrEP was 55.7% (50.6–60.2%), which was similar to the study conducted in America among Air Force health care providers (55%)36, Australia (51%) and in International AIDS Society-USA (IAS-USA) (51%)28. However, it is lower than the study done in the United Kingdom (80%)20, Tennessee Medical Center in America (78.75%)8, Italy (64.5%)23, and study in Florida 79%39. The possible explanation for this difference could be the tool (self-rated questionnaire) they used to rate the knowledge, countries that haven’t specific policies related to PrEP, and the other explanation could be study participants in the UK and America had an experience of being included in the previous study8.

On the other hand, health care providers who had good knowledge (55.7%) are higher than the study conducted in Boston Medical School (44%)26 and Rwanda < 50%40. This variation might be due to the study period, data collection method (they use a convenient sampling technique), late introduction of PrEP service, and then conducted in a small (51) study participants.

This study also found that healthcare providers who had work experience greater than or equal to 10 years had a significant association with a good knowledge of PrEP. HCPs who had this much experience were 2.5 times more likely to be knowledgeable than those who had less than 10 years of work experience (AOR 2.52). This study result is similar to the study conducted in New England26 and the USA Air Force36. The possible explanation could be health care providers who have more experience have a chance to participate in training and workshops related to HIV prevention strategies like PrEP, so greater engagement with certain continuing education tools and training influences PrEP knowledge. The other explanation might be young sexually active patients interested in PrEP may be more likely to seek out highly experienced HCPs41,42.

The other finding of this study was the significant association between the knowledge of PrEP and the sex of participants (males were approximately two times more likely knowledgeable than female healthcare providers (AOR 1.67). This study is in line with the study conducted in the UK and USA, which stated that there was a statistically significant difference in the proportion of male and female respondents who rated their knowledge of PrEP as high or medium.20,35,36.

The knowledge of healthcare providers was also highly associated with the attitudes of study participants. Those providers who had favorable attitudes to PrEP had a great association with a good knowledge of PrEP (AOR 1.92). This result is in line with the study conducted in Mexico and Brazil43 as well as in Florida39. The reason could be those healthcare providers who have a favorable attitude are eager to welcome the program and read the studies related to PrEP. The other reason might be providers who have favorable attitudes may read literature related to the efficacy and side effects of PrEP medication to increase the adherence of their patients44.

HCPs who had good sexual behavior were 2 times more likely to have a favorable attitude than those who had poor sexual behavior (AOR 1.85). This study is in line with a study conducted in Thailand and America38,45. The study found that discussing sexual risk history with patients, frequency of taking a sexual history, ever prescribing antiretroviral for HIV prevention, and offering patients HIV testing and linking to STI clinics for high-risk patients were significantly associated with independent variables with knowledge of PrEP46. The possible explanation could be those providers read different literature about HIV prevention strategies to cascade their daily activities or to answer questions raised by their patients21. The other reason could be those practicing sexual behavior activities had training on HIV prevention methods.

The other finding in this study was that 49% (45.6–55.7%) of healthcare providers discussed PrEP with high-risk patients, which is in line with the study in Florida (50%)39, greater than the study conducted in the US navy (29.9%)46. But it is lower than the study conducted in Italy (69%)23. This difference might be providers’ perception that patients do have high-risk behaviors and most patients have a low risk for infection and it may include a lack of training regarding PrEP, such as how to offer PrEP47. Another possible explanation is response bias, for example, providers know that they should be discussing and prescribing PrEP to high-risk patients according to practice guidelines, so they indicated that they were willing to do so when additional factors impact compliance in practice23.

The other pertinent finding of this study was the attitudes of health care providers about HIV PrEP was 60.2% (55.0–65.0%), which was similar to the study conducted in Tanzania (61%)24, and the multicenter study in Uganda, Botswana, and South Africa, which is less than 60%10. However, this finding is less than the study conducted in America (pooled prevalence of provider attitudes was 68%)48 and Italy (79%)23 The possible explanation for this difference could be the tool (self-rated questionnaire) they used to rate the attitudes. The other explanation could be the time of adoption of the program, those countries have accepted the PrEP program since 20159, so providers had a chance to get training and symposiums related to HIV prevention. However, the current study was conducted after 3 years of implementation in Ethiopia.

Similarly, these studies are also lower than the study done in Belgium (78.4%)49, South Africa (79%), and sub-Saharan African countries (66%)10,44. The possible explanation for this difference was that to study participants this study believed that promoting HIV testing and treating HIV-infected patients is more important than offering PrEP. On the other finding, this result was much greater than the study conducted in Rwanda, which is 40%. This discrepancy related to study participants in that study believed that PrEP leads patients to highly risky sexual behavior (59.3%) and is related to an increase in sexually transmitted diseases (58.3%)40.

The finding of this study showed that significant association between the attitudes of HCPs and the formal training of PrEP (trained HCPs were 2 times more likely favorable attitudes than untrained health care providers (AOR 2.15). This study is in line with the study conducted in Kenya42, Tanzania24, Nigeria41, and South Africa44. The possible explanation for this association is that formal training is the key to recording accurate and reliable data (efficacy; adherence, the side effect of PrEP) and it increases the attitudes of HCPs28.

The favorable attitudes of health care providers were also highly associated with reading the PrEP guideline, Study participants who read the guideline were approximately two times more likely to have a favorable attitude about HIV pre-exposure prophylaxis as compared to health care providers who didn’t read about PrEP guideline (AOR 1.66). This finding is in line with the study conducted at Tennessee Medical Center8, Florida39, Germany22, and Kenya25. The possible reason might be those who read the guideline get a clear picture of PrEP and more detailed information about it, so HCPs who read the guideline might have a favorable attitude9.

The main concerns about PrEP found in our study were adherence to PrEP and long-term side effects, and it increases risky sexual behavior, which has also been found in other studies in Belgium. As found in other studies, addressing the belief that PrEP is an effective intervention to prevent HIV4,37 and that it is a good prevention strategy may be crucial to enhancing the acceptance of PrEP among HCPs.

The favorable attitudes of healthcare providers were also highly associated with the knowledge of PrEP, knowledgeable participants had a favorable attitude about HIV pre-exposure prophylaxis as compared to healthcare providers who did not know about PrEP (AOR 1.78). This finding is in line with the study conducted at Tennessee Medical Center8, Germany22, and Kenya25. This finding may be explained by that less knowledgeable physicians possibly had more HIV-PrEP concerning issues about medication adherence behavior and risk of developing HIV drug resistance in real-life clinical practice38.

A finding that was associated with a favorable attitude towards PrEP was profession (nurses were more likely to have a favorable attitude by three times as compared to medical doctors (AOR 2.7). This study is in line with the study conducted in Washington20, and Thailand36, which found that nurses (73%) have a higher attitude toward HIV PrEP than physicians. This discrepancy may be due to the preview paradox (physicians believing that PrEP services must be given by other HCPs like nurses and clinical officers) and this paradox leads them to an unfavorable attitude15.

Conclusion and recommendations

In general, the finding of this study shows that the knowledge and attitudes of healthcare providers who were working in East Gojjam zone facilities were low, even more than half of healthcare providers in the East Gojjam zone had good knowledge and a favorable attitude. This study showed that sex (men), service years greater than 10 years, attitudes, and sexual behavior were found to be significantly associated with the PrEP knowledge of healthcare providers. Profession (being a nurse), training, reading the guidelines, and good sexual behavior were significantly associated with the favorable attitudes of healthcare providers towards HIV pre-exposure prophylaxis.

Highly experienced HCPs should share their experience with those who have less experience. Training to female HCPs and clinicians with limited work experience should undergo PrEP-specific training to increase and promote the use of PrEP among high-risk groups and reduce the risk of HIV infections. Health facilities should make available PrEP guidelines within their workplace and standardize written PrEP. The study focuses on the knowledge and attitudes of HCPs in geographically limited areas so, we recommend that future researchers study nationwide by including the practice.

Limitations of the study

The study may be subjected to the response set bias from the respondents. In addition to the above limitation, the sexual behavior component may have been influenced by social desirability bias.

Acknowledgements

We would like to thank Shebel Berenta Hospital for funding to do this research. Our acknowledgment also extends to Debre Markos University staff for their support. We would like to acknowledge data collectors and study participants for providing valuable information and for the success of this research.

Abbreviations

AGYW

Adolescent girls and young women

AIDS

Acquired immune compromised syndrome

CVI

Content validity index

FMOH

Federal Ministry of Health

HCPS

Health care providers

I-CVI

Item content validity index

PLWA

People living with AIDS

PrEP

Pre Exposure prophylaxis

SHAs

Sexual health advisors

TDF/3TC

Tenofovir Disoproxil Fumarate + Lamuvidine

UNAIDS

United Nations Program on HIV/AIDS

Author contributions

G.M. writing original draft preparation: G.M., A.D., T.L., A.A. Methodology, Formal analysis G.M., A.D., T.L., A.A. All authors reviewed, read, edited, and approved the final manuscript.

Funding

Shebel Berenta Hospital in collaboration with Debre Markos University.

Data availability

The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Colvin CJ. HIV/AIDS, chronic diseases and globalisation. Glob. Health. 2011;7(1):1–6. doi: 10.1186/1744-8603-7-31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Carter MR, Aaron E, Nassau T, Brady KA. Knowledge, attitudes, and PrEP prescribing practices of health care providers in Philadelphia, PA. J. Prim. Community Health. 2019;10:2150132719878526. doi: 10.1177/2150132719878526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Moore, E. et al. Tennessee healthcare provider practices, attitudes, and knowledge around HIV pre-exposure prophylaxis. J. Prim. Community Health11, 2150132720984416 (2020). [DOI] [PMC free article] [PubMed]
  • 4.Federal, H. HIV Prevention in Ethiopia National Road Map 2018–2020 (Federal HIV/AIDS Prevention and Control Office Addis Ababa, 2018).
  • 5.Carter MR, Aaron E, Nassau T, Brady KA. Knowledge, attitudes, and PrEP prescribing practices of health care providers in Philadelphia, PA. J. Prim. Care Community Health. 2019;10:2150132719878526. doi: 10.1177/2150132719878526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Zhang C, McMahon J, Fiscella K, Przybyla S, Braksmajer A, LeBlanc N, et al. HIV pre-exposure prophylaxis implementation cascade among health care professionals in the United States: Implications from a systematic review and meta-analysis. AIDS Patient Care STDS. 2019;33(12):507–527. doi: 10.1089/apc.2019.0119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Ajayi AI, Mudefi E, Yusuf MS, Adeniyi OV, Rala N, Goon DT. Low awareness and use of pre-exposure prophylaxis among adolescents and young adults in high HIV and sexual violence prevalence settings. Medicine. 2019;98(43):e17716. doi: 10.1097/MD.0000000000017716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Moore E, Kelly SG, Alexander L, Luther P, Cooper R, Rebeiro PF, et al. Tennessee healthcare provider practices, attitudes, and knowledge around HIV pre-exposure prophylaxis. J. Prim. Care Community Health. 2020;11:2150132720984416. doi: 10.1177/2150132720984416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Karim SSA, Baxter C. HIV pre-exposure prophylaxis implementation in Africa: Some early lessons. Lancet Glob. Health. 2021;9(12):e1634–e1635. doi: 10.1016/S2214-109X(21)00460-5. [DOI] [PubMed] [Google Scholar]
  • 10.Lanham M, Ridgeway K, Mireku M, Nhamo D, Pillay D, Murire M, et al. Health care providers’ attitudes toward and experiences delivering oral PrEP to adolescent girls and young women in Kenya, South Africa, and Zimbabwe. BMC Health Serv. Res. 2021;21(1):1–12. doi: 10.1186/s12913-021-06978-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Bekker LG, Rebe K, Venter F, Maartens G, Moorhouse M, Conradie F, et al. Southern African guidelines on the safe use of pre-exposure prophylaxis in persons at risk of acquiring HIV-1 infection. South. Afr. J. HIV Med. 2016;17(1):455. doi: 10.4102/sajhivmed.v17i1.455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Baeten, J. et al. Near elimination of HIV transmission in a demonstration project of PrEP and ART. Conference on Retroviruses and Opportunistic Infections (CROI) (2015).
  • 13.Organization WH. WHO Implementation Tool for Pre-exposure Prophylaxis (PrEP) of HIV Infection: Module 5: Monitoring and Evaluation (World Health Organization, 2018).
  • 14.Ross I, Mejia C, Melendez J, Chan PA, Nunn AC, Powderly W, et al. Awareness and attitudes of pre-exposure prophylaxis for HIV prevention among physicians in Guatemala: Implications for country-wide implementation. PLoS ONE. 2017;12(3):e0173057. doi: 10.1371/journal.pone.0173057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Pleuhs B, Quinn KG, Walsh JL, Petroll AE, John SA. Health care provider barriers to HIV pre-exposure prophylaxis in the United States: A systematic review. AIDS Patient Care STDs. 2020;34(3):111–123. doi: 10.1089/apc.2019.0189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Coalition, AVA. Global PrEP Trackerhttps://www.prepwatch.org/resource/global-prep-tracker. Accessed; 2022.
  • 17.Country, E. & Plan, R. O. Strategic Direction Summary 2021 (2021).
  • 18.Desai, M., Field, N., Grant, R. & McCormack, S. J. B. Recent Advances in Pre-exposure Prophylaxis for HIV 359 (2017). [DOI] [PMC free article] [PubMed]
  • 19.Maude, R., Volpe, G. & Stone D. Knowledge, attitudes and practice of pre-exposure prophylaxis (PrEP) against HIV infection of medical providers at an academic center. Open Forum Infect. Dis. 4(Suppl 1), S437 (2017).
  • 20.Desai M, Gafos M, Dolling D, McCormack S, Nardone A. Healthcare providers' knowledge of, attitudes to and practice of pre-exposure prophylaxis for HIV infection. HIV Med. 2016;17(2):133–142. doi: 10.1111/hiv.12285. [DOI] [PubMed] [Google Scholar]
  • 21.Lane W, Heal C, Banks J. HIV pre-exposure prophylaxis: Knowledge and attitudes among general practitioners. Aust. J. Gen. Pract. 2019;48(10):722–727. doi: 10.31128/AJGP-02-19-4860. [DOI] [PubMed] [Google Scholar]
  • 22.Kutscha F, Gaskins M, Sammons M, Nast A, Werner RN. HIV pre-exposure prophylaxis (PrEP) counseling in Germany: Knowledge, attitudes and practice in non-governmental and in public HIV and STI testing and counseling centers. Front. Public Health. 2020;8:298. doi: 10.3389/fpubh.2020.00298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Puro V, Palummieri A, De Carli G, Piselli P, Ippolito G. Attitudes towards antiretroviral Pre-exposure prophylaxis (PrEP) prescription among HIV specialists. BMC Infect. Dis. 2013;13:217. doi: 10.1186/1471-2334-13-217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Pilgrim N, Jani N, Mathur S, Kahabuka C, Saria V, Makyao N, et al. Provider perspectives on PrEP for adolescent girls and young women in Tanzania: The role of provider biases and quality of care. PLoS ONE. 2018;13(4):e0196280. doi: 10.1371/journal.pone.0196280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Mireku, M. et al. Health care providers’ knowledge, attitudes, and practices towards provision of PrEP to adolescent girls and young women in Kenya. HIV Research for Prevention Conference (2018).
  • 26.Krakower DS, Oldenburg CE, Mitty JA, Wilson IB, Kurth AE, Maloney KM, et al. Knowledge, beliefs and practices regarding antiretroviral medications for HIV prevention: Results from a survey of healthcare providers in New England. PloS ONE. 2015;10(7):e0132398. doi: 10.1371/journal.pone.0132398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Organization WH. Consolidated Guidelines on HIV Prevention, Testing, Treatment, Service Delivery and Monitoring: Recommendations for a Public Health Approach (World Health Organization, 2021). [PubMed]
  • 28.Blumenthal J, Jain S, Krakower D, Sun X, Young J, Mayer K, et al. Knowledge is Power! Increased provider knowledge scores regarding pre-exposure prophylaxis (PrEP) are associated with higher rates of PrEP prescription and future intent to prescribe PrEP. AIDS Behav. 2015;19(5):802–810. doi: 10.1007/s10461-015-0996-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Goparaju L, Praschan NC, Warren-Jeanpiere L, Experton LS, Young MA, Kassaye S. Stigma, partners, providers and costs: Potential barriers to PrEP uptake among US women. J. AIDS Clin. Res. 2017;8(9):730. doi: 10.4172/2155-6113.1000730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Marcus JL, Hurley LB, Dentoni-Lasofsky D, Ellis CG, Silverberg MJ, Slome S, et al. Barriers to preexposure prophylaxis use among individuals with recently acquired HIV infection in Northern California. AIDS Care. 2019;31(5):536–544. doi: 10.1080/09540121.2018.1533238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Mayer KH, Agwu A, Malebranche D (2007) Barriers to the wider use of pre-exposure prophylaxis in the United States: A narrative review. Adv. Ther. 37(5), 1778–1811. [DOI] [PMC free article] [PubMed]
  • 32.Ethiopian Public Health Institute E, Federal Ministry of Health F, Icf. Ethiopia Mini Demographic and Health Survey 2019 (EPHI/FMoH/ICF, 2021).
  • 33.Aynalem BY, Melesse MF. Health extension service utilization and associated factors in East Gojjam zone, Northwest Ethiopia: A community-based cross-sectional study. PLoS ONE. 2021;16(8):e0256418. doi: 10.1371/journal.pone.0256418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Authority CS. Ethiopia Demographic and Health Survey (2019).
  • 35.Wood BR, McMahan VM, Naismith K, Stockton JB, Delaney LA, Stekler JD. Knowledge, practices, and barriers to HIV preexposure prophylaxis prescribing among Washington state medical providers. Sex. Transm. Dis. 2018;45(7):452–458. doi: 10.1097/OLQ.0000000000000781. [DOI] [PubMed] [Google Scholar]
  • 36.Hakre S, Blaylock JM, Dawson P, Beckett C, Garges EC, Michael NL, et al. Knowledge, attitudes, and beliefs about HIV pre-exposure prophylaxis among US Air Force Health Care Providers. Medicine. 2016;95(32):e4511. doi: 10.1097/MD.0000000000004511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.MOH. FDRE Implementation Tool for Pre-exposure Prophylaxis (PrEP) of HIV Infection: Monitoring and Evaluation (MOH, 2019).
  • 38.Wisutep P, Sirijatuphat R, Navanukroh O, Phatharodom P, Werarak P, Rattanasuwan W. Attitudes towards, knowledge about, and confidence to prescribe antiretroviral pre-exposure prophylaxis among healthcare providers in Thailand. Medicine. 2021;100(49):e28120. doi: 10.1097/MD.0000000000028120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Gunn LH, Janson B, Lorjuste I, Summers L, Burns P, Bryant T., 3rd Healthcare providers' knowledge, readiness, prescribing behaviors, and perceived barriers regarding routine HIV testing and pre-exposure prophylaxis in DeLand, Florida. SAGE Open Med. 2019;7:2050312119836030. doi: 10.1177/2050312119836030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Kambutse I, Igiraneza G, Ogbuagu O. Perceptions of HIV transmission and pre-exposure prophylaxis among health care workers and community members in Rwanda. PLoS ONE. 2018;13(11):e0207650. doi: 10.1371/journal.pone.0207650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Abayomi JA, Adefunke A, Olugbemiga P, Oluwalusi E, Omolola O. Knowledge, attitudes and practice of healthcare workers towards availability of antiretroviral pre-exposure prohylaxis in Nigeria. J. Clin. Res. HIV AIDS Prev. 2018;3(3):46–59. doi: 10.14302/issn.2324-7339.jcrhap-18-2333. [DOI] [Google Scholar]
  • 42.Irungu EM, Ngure K, Mugwanya K, Mugo N, Bukusi E, Wamoni E, et al. Training health care providers to provide PrEP for HIV serodiscordant couples attending public health facilities in Kenya. Glob. Public Health. 2019;14(10):1524–1534. doi: 10.1080/17441692.2019.1588908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Vega-Ramirez H, Torres TS, Guillen-Diaz C, Pimenta C, Diaz-Sosa D, Konda KA, et al. Awareness, knowledge, and attitudes related to HIV pre-exposure prophylaxis and other prevention strategies among physicians from Brazil and Mexico: A cross-sectional web-based survey. BMC Health Serv. Res. 2022;22(1):532. doi: 10.1186/s12913-022-07900-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Joseph Davey DL, Daniels J, Beard C, Mashele N, Bekker L-G, Dovel K, et al. Healthcare provider knowledge and attitudes about pre-exposure prophylaxis (PrEP) in pregnancy in Cape Town, South Africa. AIDS Care. 2020;32(10):1290–1294. doi: 10.1080/09540121.2020.1782328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Walsh JL, Petroll AE. Factors related to pre-exposure prophylaxis prescription by U.S. primary care physicians. Am. J. Prev. Med. 2017;52(6):e165–e172. doi: 10.1016/j.amepre.2017.01.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Wilson K, Beckett CG, Blaylock JM, Okulicz JF, Scott PT, Hakre S. Provider knowledge gaps in HIV PrEP affect practice patterns in the US Navy. Mil. Med. 2020;185(1–2):e117–e124. doi: 10.1093/milmed/usz131. [DOI] [PubMed] [Google Scholar]
  • 47.Castel AD, Feaster DJ, Tang W, Willis S, Jordan H, Villamizar K, et al. Understanding HIV care provider attitudes regarding intentions to prescribe PrEP. J. Acquir. Immune Defic. Syndr. 2015;70(5):520–528. doi: 10.1097/QAI.0000000000000780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Krakower DS, Mayer KH. The role of healthcare providers in the roll out of preexposure prophylaxis. Curr. Opin. HIV AIDS. 2016;11(1):41–48. doi: 10.1097/COH.0000000000000206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Reyniers T, Vuylsteke B, Pirotte B, Hoornenborg E, Bil JP, Wouters K, et al. Physicians’ preparedness for pre-exposure prophylaxis: Results of an online survey in Belgium. Sex. Health. 2018;15(6):606–611. doi: 10.1071/SH18072. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES